Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Cvs Group Plc | CVSG | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 1.00 | 0.12% | 832.00 | 16:35:17 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 840.00 | 818.00 | 840.00 | 832.00 | 831.00 |
| Industry Sector |
|---|
| GENERAL RETAILERS |
| Announcement Date | Type | Currency | Dividend Amount | Ex Date | Record Date | Payment Date |
|---|---|---|---|---|---|---|
| 26/09/2024 | Final | GBP | 0.08 | 31/10/2024 | 01/11/2024 | 29/11/2024 |
| 21/09/2023 | Final | GBP | 0.075 | 02/11/2023 | 03/11/2023 | 08/12/2023 |
| 22/09/2022 | Final | GBP | 0.07 | 17/11/2022 | 18/11/2022 | 02/12/2022 |
| 23/09/2021 | Final | GBP | 0.065 | 18/11/2021 | 19/11/2021 | 03/12/2021 |
| Top Posts |
|---|
Posted at 20/11/2024 07:59 by waldron DividendSubject to shareholder approval at the AGM, CVS intends to pay its previously announced final dividend of 8.0 pence per ordinary share on 29 November 2024 to holders on the register as at 1 November 2024. The ex-dividend date was 31 October 2024. Outlook Whilst the Board remains mindful of headwinds in the UK, the fundamental need for high quality veterinary care remains strong, the expansion into Australia is progressing well and CVS remains well positioned to deliver attractive growth in shareholder value over the medium term. The recently announced UK government budget changes will result in a significant increase in employment costs with effect from April 2025. Whilst these increases will only apply in the final quarter of this financial year, the annualised impact to the year ending 30 June 2026 is estimated to be £8m from the national insurance scheme changes. The Group expects to substantially mitigate these through growth, efficiencies and purchasing synergies in Australia. The Board remains confident in the Group's ability to deliver full year 2025 results in line with market expectations. |
Posted at 08/10/2024 07:19 by waldron CVS Group (LON:CVSG) Shares Cross Above 200 Day Moving Average - Time to Sell?Written by MarketBeat October 4, 2024 CVS Group plc (LON:CVSG - Get Free Report) passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 1,054.38 ($14.10) and traded as high as GBX 1,124 ($15.03). CVS Group shares last traded at GBX 1,064 ($14.23), with a volume of 349,914 shares changing hands. Get CVS Group alerts: Wall Street Analyst Weigh In Separately, Berenberg Bank reissued a "buy" rating and issued a GBX 2,370 ($31.70) price objective on shares of CVS Group in a research note on Thursday, July 25th. The company has a quick ratio of 0.90, a current ratio of 1.09 and a debt-to-equity ratio of 110.48. The firm has a market capitalization of £760.44 million, a P/E ratio of 2,905.56, a price-to-earnings-gr CVS Group Increases Dividend The company also recently disclosed a dividend, which will be paid on Friday, November 29th. Stockholders of record on Thursday, October 31st will be issued a dividend of GBX 8 ($0.11) per share. This is an increase from CVS Group's previous dividend of $7.50. The ex-dividend date of this dividend is Thursday, October 31st. This represents a dividend yield of 0.71%. CVS Group's payout ratio is currently 2,222.22%. Insider Activity at CVS Group In other CVS Group news, insider Richard Gray bought 1,600 shares of the firm's stock in a transaction dated Wednesday, July 10th. The stock was bought at an average cost of GBX 1,019 ($13.63) per share, with a total value of £16,304 ($21,808.45). 5.83% of the stock is currently owned by insiders. CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses. |
Posted at 26/9/2024 06:56 by waldron Latest DividendsSummary Previous dividend Next dividend Status Paid Declared Type Final Final Per share 7.5p 8p Declaration date 21 Sep 2023 (Thu) 26 Sep 2024 (Thu) Ex-div date 02 Nov 2023 (Thu) 31 Oct 2024 (Thu) Pay date 08 Dec 2023 (Fri) 29 Nov 2024 (Fri) DIVIDENDMAX |
Posted at 18/3/2024 13:38 by roddyb I am hoping this will recover but there are very valid concerns as to how these companies price their services and fail to disclose pricing and dissuade pet owners from shopping around. The CMA are going to land some blows just as they did with Dignity Funeral services.Management will be scared to do share buybacks during the CMA investigation and probably scared to pay an increased dividend? They will certainly be delaying purchasing any more UK vet practices. Not looking good for the next 6 months. |
Posted at 16/3/2024 06:37 by lomax99 CVS discount is too high, says LiberumThe discount at which veterinary group CVS (CVSG) trades is 'too high', given the competition watchdog's review into vet practices is likely to prove there is no case to answer, says Liberum.Analyst Seb Jantet retained his 'buy' recommendation and target price of £22 on the stock, which gained 1.4% to £14.92 at the end of last week after its interim results. The shares have shed 21% over the year following the Competitions & Markets Authority (CMA) decision to investigate whether vets were providing consumers with value for money.Jantet said there was not a lot of new information in the result but added that 'we are still waiting for the most important piece of information, being the CMA's initial decision which is still expected in early 2024'.'While the shares have recovered a little over the last few months, they are still trading on undemanding multiples both in absolute terms and in relation to historic ratings, on a current year 2024 embedded value to pre-tax profit multiple of 9.9 times,' he said.'While we accept that the CMA uncertainty warrants a discount over the historic rating of around 15 times, the discount looks too high to us, especially given our view that there is a good chance the CMA will conclude there isn't a case to answer when it next updates.' |
Posted at 12/3/2024 09:23 by undervaluedassets Overdone. This is old news re-issued.Properly cheap now Have watched and admired CVSG for years but the multiple was always too big for me. (pe of 127 and 80 in 2020 and 2021 respectively) On a current pe of 20 and with a pe of 15 pencilled for 2024 this is now a looks a reasonable punt The 16 million pet owners are a huge addressable market which is not disappearing and into which the company can grow. |
Posted at 29/2/2024 08:32 by ariane DividendsA dividend of 7.5p (December 2022: 7.0p) per share was paid in December 2023 in respect of the financial year ended 30 June 2023. The Board will continue to review its dividend policy and anticipates the payment of a final dividend in respect of the current financial year, which will be payable in December 2024. In line with our customary practice, the amount of this dividend will be dependent on the outcome of the full year results and the growth capital needs of the business. Current trading & Outlook We remain confident of delivering sustainable long-term growth and delivery of our strategic goals. We continue to execute on the strategy outlined at our Capital Markets Day in November 2022 and we extended our bank facilities in January 2024 so that we have committed bank facilities through to February 2028. We continue to be mindful of the wider macroeconomic backdrop and the potential impact on demand as well as continued inflationary pressures on margins over the near term. However, the Board remains confident that full year results will be in line with market expectations and the strategy remains appropriate to deliver longer term sustainable growth in value. We will continue our investment in our people, technology and our clinical facilities in order to support further organic growth. This will be augmented by investment in our exciting pipeline of selective acquisitions and development of exceptional Greenfield sites. In H2 2024 to date, we have completed a further small animal practice acquisition in the UK for initial consideration of £5.2m. The Board would like to acknowledge and thank all members of the CVS team for their efforts to provide the very best care for animals, and with their support, we look forward to sharing continued success in the future. Deborah Kemp Interim Chair 29 February 2024 |
Posted at 26/1/2024 11:31 by iamnotanumber6 Berenberg believes CVS can deliver double-digit earnings growthVeterinary services provider CVS Group (CVSG) is on track with its plan to grow, invest and acquire, a story that remains ‘highly attractive’, says Berenberg. Analyst Calum Battersby retained his ‘buy’ recommendation and target price of £23.70 on the stock, which was trading at £16.73 on Thursday. A first-half trading update for the six months to the end of 2023 showed the group’s ‘strong performance’ has continued, Battersby said, with 6% like-for-like revenue growth, stable year-on-year margins and a further 5.4% revenue contribution from acquisitions. Battersby said the company’s growth strategy is ‘clearly working’ as it enjoyed a ‘combination of strong organic growth, investments in practice refurbishments and relocations, acquisitions in the UK and acquisitions in Australia’. Although the market is currently focusing on the next update from the Competition and Markets Authority which is looking into value for money offered by vets, Battersby said the ‘underlying CVS story remains highly attractive’ and said investors ‘can expect double-digit compounding earnings growth for the foreseeable future’. |
Posted at 30/11/2023 16:12 by travis2 Agreed. I have been a long term observer of CVSG. They not only own a large number of Vet practices but the killer blow is that they also own one of the biggest online vet medicine outlets. Hence they profit twice, when selling to the practices as well as to the general public who have paid the vet for their animal's prescription. It's a win win for them. The regulator will make some token changes to make it look like they have done their job, but ultimately this business is solid and profitability will only increase in the long term. |
Posted at 21/9/2023 06:43 by ariane DividendsIn light of the continued growth of the Group and its positive operating cash generation, the Board is recommending a continuation of our progressive dividend policy, with the payment of a final dividend of 7.5p per Ordinary share (2022: 7.0p). The ex-dividend date is 2 November 2023 and the dividend payment date is 8 December 2023. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
